Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease

Alzheimer disease (AD) is characterized by the progressive deposition of the 42-residue amyloid beta protein (Abeta) in brain regions serving memory and cognition. In animal models of AD, immunization with Abeta results in the clearance of Abeta deposits from the brain. However, a trial of vaccinati...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 112; no. 3; pp. 415 - 422
Main Authors Monsonego, Alon, Zota, Victor, Karni, Arnon, Krieger, Jeffery I., Bar-Or, Amit, Bitan, Gal, Budson, Andrew E., Sperling, Reisa, Selkoe, Dennis J., Weiner, Howard L.
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.08.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer disease (AD) is characterized by the progressive deposition of the 42-residue amyloid beta protein (Abeta) in brain regions serving memory and cognition. In animal models of AD, immunization with Abeta results in the clearance of Abeta deposits from the brain. However, a trial of vaccination with synthetic human Abeta1-42 in AD resulted in the development of meningoencephalitis in some patients. We measured cellular immune responses to Abeta in middle-aged and elderly healthy subjects and in patients with AD. A significantly higher proportion of healthy elderly subjects and patients with AD had strong Abeta-reactive T cell responses than occurred in middle-aged adults. The immunodominant Abeta epitopes in humans resided in amino acids 16-33. Epitope mapping enabled the identification of MHC/T cell receptor (TCR) contact residues. The occurrence of intrinsic T cell reactivity to the self-antigen Abeta in humans has implications for the design of Abeta vaccines, may itself be linked to AD susceptibility and course, and appears to be associated with the aging process.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Address correspondence to: Howard L. Weiner, Center for Neurologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, 77 Avenue Louis Pasteur, HIM 730, Boston, Massachusetts 02115, USA. Phone: (617) 525-5300; Fax: (617) 525-5252; E-mail: hweiner@rics.bwh.harvard.edu.
ISSN:0021-9738
DOI:10.1172/JCI200318104